Cambridge Nutritional Sciences PLC Grant of Options

RNS Number : 4766R

Cambridge Nutritional Sciences PLC

06 June 2024

 

 

06 June 2024

Cambridge Nutritional Sciences PLC

("CNSL" or the "Company")

Grant of Options

CNSL, (AIM:CNSL) the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that on 6 June 2024 the Board granted share options (the "Options") over its ordinary shares of 4.0 pence each ("Ordinary Shares") to the Chair, Carolyn Rand, Non-Executive Director, and to Jeremy Millard, Non-Executive Director.

Following this grant of Options, the Company has options in issue over 18,184,049 Ordinary Shares, representing approximately 8% per cent. of the Company's total issued share capital.

Director	Number of Options granted on  6 June 2024	Exercise Price	Total options held post issue
Carolyn Rand (Chair)	9,930,000	4.0p	9,930,000
Jeremy Millard	450,000	4.0p	783,334

 

Grant of Options

The Company has granted the Options to incentivise non-executive director ("NED") performance for the benefit of all Shareholders and to more effectively reward active NED engagement.

The Options are subject to time conditions (as set out below); good/bad leaver provisions; and being a director of the Company on the date of vesting.

 

Vesting criteria for Options are subject to time conditions as follows:

Amount Vesting	Time Condition
34 per cent. ("Tranche One")	On the first anniversary of 6 June 2024
33 per cent. ("Tranche Two")	On the second anniversary of 6 June 2024
33 per cent. ("Tranche Three")	On the third anniversary of 6 June 2024

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).

For further information, please contact:

Cambridge Nutritional Sciences Plc Jag Grewal, Chief Executive Officer	www.cnsplc.com [e-mail]
Cavendish Capital Markets Limited Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance) Nigel Birks / Harriet Ward (ECM)	Tel: [phone]

 

 

About Cambridge Nutritional Sciences Plc

Cambridge Nutritional Sciences Plc (AIM: CNSL) is the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Carolyn Rand
2.	Reason for the notification
a)	Position/status	Chair, Non-Executive Chair
b)	Initial notification/ Amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cambridge Nutritional Sciences plc
b)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Options over Ordinary Shares of 4.0p each
	Identification code	ISIN: GB00B1VCP282
b)	Nature of the transaction	Grant of Options
c)	Price(s) and volume(s)	Price(s) Volume(s) 4.0p 9,930,000
d)	Aggregated information - Aggregated volume - Price	n/a
e)	Date of the transactions	6 June 2024
f)	Place of the transactions	Outside a trading venue

 

 

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jeremy Millard
2.	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification/ Amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cambridge Nutritional Sciences plc
b)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Options over Ordinary Shares of 4.0p each
	Identification code	ISIN: GB00B1VCP282
b)	Nature of the transaction	Grant of Options
c)	Price(s) and volume(s)	Price(s) Volume(s) 4.0p 450,000
d)	Aggregated information - Aggregated volume - Price	n/a
e)	Date of the transactions	6 June 2024
f)	Place of the transactions	Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHBUGDLUDGDGSL